PCOS Has a New Name — And It's a Big Deal for Women's Health

If you've been managing PCOS, or suspecting you might have it, we have some big news to share.

As of May 12, 2026, PCOS officially has a new name: PMOS, which stands for Polyendocrine Metabolic Ovarian Syndrome. The change was announced in a landmark consensus study published in The Lancet and presented at the European Congress of Endocrinology. This wasn't a rushed rebranding — it was the result of over a decade of advocacy, research, and global collaboration involving more than 22,000 patients and healthcare professionals from around the world.

So what does this mean for you? Let's break it down.

Why "Polycystic Ovary Syndrome" Was Always Misleading

The name PCOS presented a multitude of problems for years, and the medical community knew it.

For starters: the "polycystic" part — implying pathological ovarian cysts — was never quite right. Most women with a PCOS diagnosis do not have ovarian cysts. In fact, women with PCOS are no more likely to develop cysts than women without PCOS. What shows up on ultrasound aren't true cysts at all. They're actually arrested follicles, meaning eggs that failed to mature within the ovaries due to hormonal fluctuations. And here's the kicker: many people with PCOS don't even show those on imaging. So a name centered around "cysts" was already setting people up for confusion before they even left the doctor's office.

But the problem ran even deeper than that. By putting the spotlight on the ovaries, the old name framed this as primarily a gynecological condition — something to be managed by OB-GYNs and mostly related to periods and fertility. And while those are absolutely real parts of the picture, PCOS is so much more than that.

This condition affects:

  • Hormones — involving insulin, androgens (like testosterone), and neuroendocrine hormones all interacting with each other

  • Metabolism — including insulin resistance, weight regulation, and elevated risks for type 2 diabetes and cardiovascular disease

  • Mental health — anxiety and depression are significantly more common in people with this condition

  • Skin and hair — acne, excess hair growth, and hair thinning are hormonal symptoms, not cosmetic side effects

  • Reproductive health — including ovulation, fertility, and menstrual cycle irregularities

When the name only pointed to one piece of that puzzle, it led to real consequences. Research shows that up to 70% of cases go undiagnosed due to misconceptions about what the condition entails. For those who get a diagnosis, it often takes years and multiple provider visits.

Patients were bounced between specialists. Metabolic risks were undertreated. And many people were left feeling like their very real, very full-body symptoms were being minimized.

Why PMOS Is a More Accurate Name

The new name, Polyendocrine Metabolic Ovarian Syndrome, was designed the reflect the complete nature of the condition.

  • Polyendocrine — acknowledges that multiple hormonal systems are involved, not just the ovaries. This is a condition rooted in how your endocrine system (your body's hormone network) functions as a whole.

  • Metabolic — gives long-overdue recognition to the metabolic features of the condition: insulin resistance, weight, cardiovascular risk, and more.

  • Ovarian — keeps the connection to reproductive health and the ovaries, which remain an important part of the picture.

This rename is truly about recognizing the full reality of what patients experience. For too long, a narrow name obscured a complex condition — and that had real consequences for how seriously it was taken, how it was researched, and how it was treated.

The renaming process itself was unprecedented in scope: over 50 patient and professional organizations were involved, including the Endocrine Society. It engaged people across all world regions, and used rigorous methods to ensure the new name reflected both scientific accuracy and the lived experiences of patients. This wasn't done lightly; it was done right.

What This Means for Women's Health

A name change might seem like a small thing, but language shapes care. Here's why this matters:

Better diagnoses, sooner. When the name accurately reflects the full condition, clinicians are better equipped to recognize it — even in patients who don't fit the "classic" picture. That means fewer years spent wondering why things feel off, and more time actually getting support.

Integrated, whole-body care. PMOS makes it clearer that this condition needs a team — not just a gynecologist, but potentially an endocrinologist, a cardiologist, a mental health provider, and more. It reframes the condition as the complex, long-term health issue it truly is.

Reduced stigma. The old name contributed to a lot of confusion and shame, particularly around weight. When people understand that PMOS is fundamentally a hormonal and metabolic condition, that changes the conversation entirely.

More research and funding. How a condition is categorized and named affects how it's prioritized in policy, research, and clinical education. A name that accurately reflects PMOS's multisystem nature opens doors to more comprehensive scientific inquiry.

Recognition for future generations. As one patient advocate said in response to the change: "This is about my daughters, their daughters, and the countless women yet to be born. We deserve clarity, understanding, and equitable healthcare from the very beginning."

The implementation plan includes a three-year transition period supported by international education and awareness campaigns, plus updates to clinical guidelines and international disease classification systems worldwide.

What We're Doing at Comma

This was incredibly exciting news to everyone at Comma. This is the kind of change that has been decades in the making, and it reflects something we believe deeply at Comma: that women's health deserves to be understood fully, not flattened into oversimplified labels.

Our team is actively working to update Sara to reflect this new terminology. We know that if you've been using Sara to track and understand your PCOS/PMOS symptoms, you deserve the most accurate, up-to-date language and framing possible. We're on it — and we'll keep you posted as updates roll out.

In the meantime, nothing changes about your tracking. Whether you've been living with PCOS/PMOS for years or are just starting to explore what your symptoms might mean, know that this moment is meaningful. The medical community just said, loudly and clearly: this condition is real, it is complex, it affects your whole body, and it deserves to be taken seriously.

And so do you.

Sources:

The Lancet: Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process

Endocrine Society: Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide

The New York Times: P.C.O.S. Has a New Name. Doctors Hope It Will Improve Care for Millions.

Live Science: 'The name was inaccurate': PCOS gets a new name after years-long effort

Next
Next

Women’s Health Week! Understanding the Most Common Reproductive Conditions